Real-world challenges. Ingenious solutions.
SPT Labtech is a team of exceptionally skilled scientists, engineers and business innovators. We have one overarching mission: to work together to accelerate life science research. Through our innovative solutions and state-of-the-art tools, we believe we can make a real difference to human health
Collaboration is at the heart of how we work. We listen to our customers and understand the challenges they face, which is why scientists and researchers globally trust us to develop exceptional, personalized solutions. We collaborate internally drawing on our teams’ breadth of expertize, from deep application knowledge to cutting-edge engineering and design. It means that when we recognize a need, we can innovate to meet it and take that idea from initial concept, to prototype, to final manufacture and market.
As an example, we’re helping drive forward challenges within genomics to resize life science with our work on miniaturization, accelerating breakthroughs and pioneering ideas in next generation sequencing. Working together with scientists, we’re achieving results not possible in larger volumes.
A broader portfolio. Bigger breakthroughs.
Following the acquisition by Battery in 2018 we have been diversifying and strengthening the SPT Labtech portfolio, allowing us to service an even broader range of needs for our customers.
In August 2019 alongside the introduction of chameleon, which enables the scalable application of cryo-electron microscopy to protein research and drug discovery, was the acquisition of Quantifoil and their portfolio of world-renowned support foils for electron microscopy. By bringing together this wealth of expertize we have established ourselves as the market leaders for next generation cryo-electron microscopy sample preparation.
In the summer of 2020, we strengthened our position in Asia with the acquisition of LBD Life Sciences, a leading instrumentation supplier in China, positioning us to meet the rapidly evolving needs of the world's fastest growing research community. We also opened an office in Japan, building on long-standing partnerships with Japanese life science distributors, enabling us to meet the needs of the community more effectively and helping to accelerate and elevate their research.
In 2021, we were able to expand our leading range of liquid handling technologies through the acquisition of Apricot Designs, a Californian company with a 30-year track record in supporting increasingly complex laboratory research requirements. As an industry leader in air displacement technology this has complemented our established positive displacement liquid handling range to create a broader and stronger portfolio. This acquisition also brings with it a successful OEM business supplying liquid handling technology to a wide range of life science partners.
2021 also saw the acquisition of BioMicroLab, a robotics automation provider, complementing our capabilities in modular, automated sample storage systems.
Combining these individual strengths within a single portfolio means we can continue to develop breakthrough instruments that not only meet today’s tough life science challenges but empower research success across an even broader spectrum in the future.
